Warfarin Sodium tablets
Company: Barr Laboratories
Approval Status: Approved March 1997
Treatment for: Anticoagulant, or "blood thinner" to keep blood clots from forming or getting larger
Areas: Cardiology/Vascular Diseases
General Information
Other Useful Resources
Seven strengths of Warfarin Sodium tablets, the generic equivalent of DuPont Merck’s anti-coagulant Coumadin, have been approved for marketing.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
